Difficulty: Medium
Average Score: 66%
Practice
Lab results reveal that your 67-year-old male patient with type 2 diabetes has a HgbA1C of 6.7%. Presently the patient is on 1000 mg of Glucophage BI With this lab value which of the following interventions does the advanced practice nurse anticipate for the patientÔÇÖs treatment plan?
Correct answer
A
Rationale
In this scenario, the correct intervention is option A: Make no change in Glucophage dose. The rationale behind this choice is based on the patient's HgbA1C level of 6.7%, which indicates fairly good blood sugar control. The advanced practice nurse would want to maintain the current treatment plan as it appears to be effective in managing the patient's diabetes.
Option B, adding a sulfonylurea drug like Diabenese, would be an aggressive approach and may increase the risk of hypoglycemia in the patient, especially considering the current HgbA1C level.
Option C, decreasing Glucophage to 500mg BID, would likely result in poorer blood sugar control as the current dose seems to be effective based on the lab results.
Option D, adding NPH insulin BID, would be an unnecessary escalation of treatment at this point, given the patient's relatively good glycemic control with the current regimen.
From an educational standpoint, it is crucial for healthcare providers to interpret lab results in the context of the individual patient and their current treatment plan. Understanding how to adjust medications based on lab values is a critical skill in pharmacology across the lifespan, especially when managing chronic conditions like diabetes in older adults. It is important to prioritize patient safety and effective management of the disease while minimizing adverse effects.
Option B, adding a sulfonylurea drug like Diabenese, would be an aggressive approach and may increase the risk of hypoglycemia in the patient, especially considering the current HgbA1C level.
Option C, decreasing Glucophage to 500mg BID, would likely result in poorer blood sugar control as the current dose seems to be effective based on the lab results.
Option D, adding NPH insulin BID, would be an unnecessary escalation of treatment at this point, given the patient's relatively good glycemic control with the current regimen.
From an educational standpoint, it is crucial for healthcare providers to interpret lab results in the context of the individual patient and their current treatment plan. Understanding how to adjust medications based on lab values is a critical skill in pharmacology across the lifespan, especially when managing chronic conditions like diabetes in older adults. It is important to prioritize patient safety and effective management of the disease while minimizing adverse effects.